Upload
others
View
2
Download
0
Embed Size (px)
Citation preview
DECISION
16 October 2017
Summary
Substances HEMPAGUARD X7 89909
Application code APP203090
Application type To import or manufacture for release any hazardous substance under
Section 28 of the Hazardous Substances and New Organisms Act 1996
(“the Act”)
Applicant Hempel (New Zealand) Ltd
Purpose of the application To import Hempaguard X7 89909, an antifouling paint with 9% copper
pyrithione as the active ingredient
Date application received 20 February 2017
Consideration date 27 September to 16 October 2017
Further information was requested from the applicant during the evaluation
of the application in accordance with section 58 of the Act. The
consideration was therefore postponed in line with section 59 of the Act.
Considered by The Chief Executive1 of the Environmental Protection Authority (“the EPA”)
Decision Approved with controls
Approval code HSR101255
Hazard classifications 3.1C, 6.1C, 6.3A, 6.5B, 6.7B, 6.8B, 6.9B, 8.3A, 9.1A
1 The Chief Executive of the EPA has made the decision on this application under delegated authority in accordance with section 19 of the Act.
2
Decision on application for approval to import or manufacture Hempaguard X7 89909 for release (APP203090)
October 2017
1. Substance
1.1. Hempaguard X7 89909 (available in different colours) contains 9% copper pyrithione as the active
ingredient, and is intended to be mixed with Hempel’s Crosslinker 98980 (in a specific ratio) to form a
ready-to-use antifouling formulation. This formulation is intended for professional use and is to be
applied by low-volume airless sprayer, and by brush and roller for smaller applications.
1.2. The applicant originally intended for Hempel’s Crosslinker 98980, a silicone-based binder, to be
considered in this application. Following discussions with the applicant, it was decided that Hempel’s
Crosslinker 98980 is more appropriate for regulation under a Group Standard. Therefore, only
Hempaguard X7 89909 is considered for approval in this application.
1.3. In 2013 the EPA reassessed antifouling paint formulations that were approved for use in New
Zealand. This led to the withdrawal of approvals for a number of substances, and the approvals for
several substances were made time-limited for a four or ten year period. The approvals for the other
antifouling paints were continued, but subject to additional controls, and this included substances with
the active ingredient (copper pyrithione) present in Hempaguard X7 89909. The considerations made
in APP201051 informed this decision on the application for the Hempaguard X7 89909.
2. Process and notification
Application receipt
2.1. The application was formally received on 20 February 2017 under section 28 of the Act. There were
unlikely to be significant public interest in this application so it was not publicly notified in accordance
with section 53(2) of the Act.
Information available for consideration
2.2. Further information was requested from the applicant during the evaluation phase in accordance with
section 58 of the Act. The consideration was therefore postponed in line with section 59 of the Act.
2.3. The information available is sufficient for assessing this application. This information includes the
application form, confidential appendices to the application and the EPA staff advice memorandum.
Notification to government departments
2.4. In accordance with section 53(4) of the Act, WorkSafe New Zealand was notified of this application
and invited to comment. No comments were received.
Legislative criteria for the application
2.5. The application was considered in accordance with section 29 of the Act. This took into account other
relevant sections of the Act, the Hazardous Substances Regulations and the Hazardous Substances
and New Organisms (Methodology) Order 1998.
3
Decision on application for approval to import or manufacture Hempaguard X7 89909 for release (APP203090)
October 2017
3. Hazardous properties, prescribed controls and exposure limits
Hazardous properties
3.1. The hazard classifications for Hempaguard X7 89909 (Table 1) were determined by the EPA using:
formulation-specific data submitted by the applicant
information on the effects of the individual components of Hempaguard X7 89909
mixture rules.
3.2. The applicant submitted formulation data on the flashpoint of Hempaguard X7 89909 and this was
used to assign the 3.1C classification.
3.3. The applicant submitted a mammalian, oral toxicity study for Hempaguard X7 89909, which showed
that the substance has an LD50 > 2000 mg/kg bw. Using this value the EPA determined that a 9.3
classification is not appropriate.
Table 1: Hazard classifications assigned to Hempaguard X7 89909
Hazard endpoint Hazard classifications
Flammable liquid 3.1C
Acute toxicity (oral) 6.1E
Acute toxicity (inhalation) 6.1C
Skin irritancy/corrosivity 6.3A
Eye irritancy/corrosivity 8.3A
Contact sensitisation 6.5B
Carcinogenicity 6.7B
Reproductive/ developmental toxicity 6.8B
Target organ or systemic toxicity (oral) 6.9B
Target organ or systemic toxicity (inhalation) 6.9B
Aquatic ecotoxicity 9.1A
Prescribed controls
3.4. The hazard classifications of Hempaguard X7 89909 determine a set of prescribed controls that is
specified by the Hazardous Substances Regulations under the Act. These prescribed controls set the
baseline for how this substance should be managed and include specifications on how the substance
is to be packaged, labelled, stored, disposed, transported, handled and used. The prescribed controls
form the basis of the final control set detailed in Appendix A.
4
Decision on application for approval to import or manufacture Hempaguard X7 89909 for release (APP203090)
October 2017
Exposure limits
3.5. Control T1 allows the EPA to set ADE (Acceptable Daily Exposure), PDE (Potential Daily Exposure)
and TEL (Tolerable Exposure Limit) values. No ADE value is set for any component of Hempaguard
X7 89909 at this time, as the risks of exposure to this substance is not likely to result in an appreciable
toxic effect to people, provided users comply with the controls in Appendix A. Therefore, the criterion
for setting an ADE value under regulation 11(1)(c) of the Hazardous Substances (Classes 6, 8 and 9)
Regulations 2001 is not met. As no ADE value has been set, then no PDE or TEL value is required to
be set.
3.6. Control T2 allows Workplace Exposure Standard (WES) values to be set for any component of a
substance to limit the exposure of people to toxic substances in places of work. The relevant WES
values listed in the WorkSafe New Zealand Standard Workplace Exposure Standards and Biological
Exposure Indices 8th Edition2, are adopted and applied. This applies for all relevant components of
this substance in accordance with regulation 30(1)(a) of the Hazardous Substances (Classes 6,8 and
9) Regulations 2001, where applicable.
3.7. Control E1 allows the EPA to set Environmental Exposure Limit (EEL) values. No EEL values are set
for any component of Hempaguard X7 89909 at this time, as the risk of adverse effects to the
environment can be adequately managed, provided users comply with the controls in Appendix A. The
default EEL values are deleted.
4. Risk and benefit assessment
Risk assessment
4.1. The risk assessment takes into account the hazardous properties of the substance, the prescribed
controls and other relevant legislation such as the Land Transport Rule 45001, Civil Aviation Act 1990
and Maritime Transport Act 1994.
4.2. The risk and benefit assessment:
considers the risks posed by Hempaguard X7 89909
determines whether any variations or additions to the prescribed controls are required to manage
the risks of this substance, and identifies controls that may be deleted.
determines whether the risks are outweighed by the benefits
Assessment of risks to human health
4.3. The human health risks have been assessed in accordance with Section 29(1) of the Act. This
assessment takes into account the full life cycle of the substance, which includes import and
manufacture, packaging, transport, storage, use and disposal.
2 Or any subsequent version of this Standard approved or endorsed by the EPA.
5
Decision on application for approval to import or manufacture Hempaguard X7 89909 for release (APP203090)
October 2017
4.4. A quantitative assessment of the risks posed by Hempaguard X7 89909 to human health was
undertaken by the EPA. Hempaguard X7 89909 contains copper pyrithione up to a concentration of
9%. This is higher than the concentrations of copper pyrithione in other antifouling paints approved
under the Act. Therefore, the risks posed by Hempaguard X7 89909 to human health and the
environment are likely to be different from the copper pyrithione-containing antifouling paints approved
under the Act.
4.5. The applicant provided the EPA with an operator risk assessment that assesses the risks of exposure
to people applying Hempaguard X7 89909 using airless spray equipment and paint brushes and
rollers. This risk assessment considers Hempaguard X7 89909 when it is mixed in an appropriate ratio
with Hempel’s Crosslinker 98980. The EPA has taken into account the available information, and has
found no evidence of synergistic effects when Hempaguard X7 89909 is mixed with Hempel’s
Crosslinker 98980.
4.6. The applicant also provided a study (in vitro percutaneous absorption following OECD 428) on the
dermal absorption of Hempaguard X7 89909. The EPA considers that this study is appropriate for
consideration.
4.7. The EPA reviewed the operator risk assessment and the dermal absorption study; and together with
its own risk assessment, determined that the risks posed by Hempaguard X7 89909 to users can be
mitigated to a negligible level. This is dependent on the use of appropriate personal protective
equipment (PPE) and respiratory protective equipment (RPE). Operators applying the substance with
an airless sprayer should wear protective gloves, double coveralls and RPE 40.
4.8. The EPA’s risk assessment concluded that the chronic risk to users applying the substance by brush
or roller is negligible. This chronic risk is negligible even without the use of PPE. However, prescribed
controls that are based on the acute hazards of Hempaguard X7 89909 (such as eye corrosivity), still
require the use of PPE, and these controls are retained on this approval.
4.9. The EPA’s risk assessment also concluded that full PPE and RPE with a protection factor of at least
10 (RPE 10) is required to reduce exposure risks to a negligible level for operators mixing and loading
the substance.
4.10. The risk posed by Hempaguard X7 89909 to human health is negligible, provided users comply with
the controls in Appendix A.
Assessment of risks to the environment
4.11. The environmental risks have been assessed in accordance with Section 29(1) of the Act. This
assessment takes into account the full life cycle of this substance. The full life cycle includes
importation and manufacture, packaging, transport, storage, use and disposal.
4.12. Antifouling paints are very toxic to the aquatic environment, with some paints also being toxic to the
terrestrial environment. However, the likelihood of a terrestrial environment being exposed to a
significant level of antifouling paint is considered unlikely given compliance with the HSNO controls,
6
Decision on application for approval to import or manufacture Hempaguard X7 89909 for release (APP203090)
October 2017
and so the environmental risk assessment for this substance focuses on the risks to the aquatic
environment.
4.13. The applicant provided the EPA with an environmental risk assessment. This assessment estimates
the Predicted Environmental Concentration (PEC) of copper pyrithione in a commercial New Zealand
harbour.
4.14. The EPA reviewed the applicant’s environmental risk assessment, and together with its own risk
assessment, determined that the risks posed by Hempaguard X7 89909 to environment is negligible.
This is dependent on compliance with the controls on Appendix A.
Assessment of risks to Māori and their relationship to the environment
Kupu arataki (Context)
4.15. The potential effects of Hempaguard X7 89909 on the relationship of Māori to the environment have
been assessed in accordance with sections 5(b), 6(d) and 8 of the Act. Under these sections all persons
exercising functions, powers and duties under this Act shall: Recognise and provide for the maintenance
and enhancement of people and communities to provide for their cultural well-being (section 5(b)), and;
take into account the relationship of Māori and their culture and traditions with their ancestral lands,
water, sites, wāhi tapu, valued flora and fauna, and other taonga (section 6(d)) and the principles of the
Treaty of Waitangi (section 8).
4.16. It is noted that Hempaguard X7 89909 triggers a number of hazardous properties giving rise to the
potential for cultural risk e.g. aquatic ecotoxicity. Cultural risk includes any negative impacts to treasured
flora and fauna species, the environment, and the general health and well-being of individuals and the
community.
4.17. In general, the introduction and use of hazardous substances has the potential to inhibit the ability of
Māori to fulfil their role as kaitiaki. This is particularly relevant when considering the guardianship of land
and water given the ecotoxic nature of Hempaguard X7 89909 to Te Marae o Tangaroa (marine
ecosystems), in particular species associated with mahinga kai (food resources), taputapu (tools and
equipment) and kōrero o mua (traditional narratives) as well as other cultural associations.
Ngā here whakapapa (Genealogical obligations)
4.18. Māori have a holistic and intergenerational view of the environment based around whakapapa
(genealogies) and whanaungatanga (relationships) connecting people and all things in the world, living
and non-living, animate and inanimate. Māori cultural beliefs and environmental frameworks use
kinship, personification and metaphor to explain the origins of, and interrelationships between, all
things. These beliefs and frameworks are maintained and transmitted to successive generations
through kōrero o mua (traditional narratives), mātauranga (knowledge systems) and tikanga
(customary values and practices).
4.19. According to Māori creation traditions, Tāne-mahuta (deity of humans, forests and forest-dwelling
species) procreated birds, insects, trees, plants and humans. As progeny of Tāne, all of these
7
Decision on application for approval to import or manufacture Hempaguard X7 89909 for release (APP203090)
October 2017
organisms share whakapapa (genealogy) with one another and are closely related. Since birds,
insects, trees and plants were created before humans, the former have tuākana (senior sibling) status
in relation to humans who are teina (junior siblings). This tuākana – teina relationship dictates that
careful consideration of potential risks and impacts on plants and animals and places a responsibility
on Māori commonly known as kaitiakitanga (guardianship, due care and diligence).
4.20. Fish and other aquatic species are descendants of Tangaroa (deity of the sea and water-dwelling
species). Many of Tangaroa’s descendants live in the domain of Maru (tutelary guardian of fresh
water). Again, whakapapa obliges us to ensure that the best interests of these related and
interconnected elements are taken care of.
4.21. Any use of, or effects on, organisms and natural resources need to be contemplated within this
fundamental construct. Compelling justification is required for any detrimental impacts.
Ngā tikanga tuku iho (Cultural legacies)
4.22. Hazardous substances that may potentially harm or adversely interfere with culturally significant
receptors are unacceptable to Māori. Any level of contamination of cultural receptors by hazardous
substances is undesirable – irrespective of the quantity of contaminants coming into contact with the
receptors, period of exposure, and the nature, scale and intensity of adverse effects.
4.23. Hazardous substances can engender both direct and indirect impacts on Māori interests. Direct
impacts are the positive or adverse effects on culturally significant receptors such as taonga species.
Indirect impacts are the consequential effects, that is, how such impacts affect the ability of Māori to
express their culture, in particular customary practices and usages associated with the affected taonga
species.
4.24. Any substance that poses risk to the web of life, and the plants and creatures within it, is an issue for
Māori. The importance to Māori of ensuring that taonga species flourish cannot be overstated
historically or contemporarily. In former times, kai moana (seafood) was vital for sustaining Māori
communities and whānau. Estuarine and marine species of plants and animals formed a critical part of
the food supply. Taonga species remain essential for continuing customary practices and meeting
cultural obligations, especially in respect of showing manaaki (hospitality) to guests on the marae,
providing whānau with traditional kai, healing people using age-old remedies, and performing rituals in
accordance with proper method and material.
Te Marae o Tangaroa (Marine ecosystems)
4.25. Māori are connected to the sea by whakapapa and history; they came to Aotearoa from the ocean, and
believe that after death their spirit returns across this vast domain of Tangaroa to the ancient homeland
of Hawaiki to join ancestors of the distant past. Te Marae o Tangaroa was a life support system for
coastal Māori – it was important in terms of sustenance, raw materials, transport, trade, warfare, identity,
literature and technology. This deeply rooted association continues today, albeit in contemporary forms
and expressions. Māori would therefore be concerned about any potentially risk to taonga species posed
by Hempaguard X7 89909.
8
Decision on application for approval to import or manufacture Hempaguard X7 89909 for release (APP203090)
October 2017
4.26. Hempaguard X7 89909 has potential to harm or interfere with a wide range of culturally significant
species in coastal and marine environments. Potentially affected taonga food species include the
following inhabitants of estuaries, harbours and bays: Tio para (dredge oyster / Bluff oyster), tio repe
(rock oyster), tio o Te Moana-nui-a-Kiwa (pacific oyster), pāua (abalone), kuku (mussel), pipi / tuatua /
toheroa (wedge clams), tuangi (cockle), tipa (scallop), kina (sea urchin), tipa (scallop), pūpū (cat’s eye),
kanae (grey mullet), aua (yellow-eyed mullet), kahawai (sea trout), araara (trevally), tāmure (snapper),
haku (yellowtail kingfish), kumukumu (gurnard), red cod (hoka), rāwaru (blue cod), mararī (butterfish),
kōkiri (leatherjacket), ngōiro (conger eel), ihe (piper), hauture (jack mackerel), pioke (rig), whai
(stingray), octopus (wheke), various pātiki (flounders), various pāpaka (crabs), kōura (crayfish) and
karengo (southern laver). Some of these creatures are prey for other culturally significant species of
ika kanihi (predatory fish), mangō (sharks), manu wai tai (sea birds) and kekeno (seals).
4.27. Māori use the bones, teeth, shells and skins of marine species for ornaments, tools and other devices.
Matau (fish hooks) and pā (fishing lures) were fashioned from bone and pāua shell. Shells were used
to make necklaces, anklets, containers, musical instruments, inlays in carvings, as well as for cutting
hair, scaling fish and scraping flax leaves in the preparation of muka (flax fibre) for a variety of uses.
4.28. Rimurapa (bull kelp) was made into bags known as pōhā for preserving and storing tītī (mutton birds).
It was used to make flutes and was also roasted and chewed. Such is the importance of rimu
(seaweed) generally that rimurapa and karengo (southern laver) are protected under the Ngāi Tahu
Claims Settlement Act 1998 from commercial harvesting within Ngāi Tahu’s customary seaweed
gathering areas. Rimu features in waiata (songs). For instance, the waiata tangi (lament) ‘Rimu rimu,
tere tere’ uses the metaphor of seaweed floating in the sea to describe the feeling of drifting in a sea
of pain and sorrow following the loss of a loved one. The word ‘rimu’ derives from ‘limu’, a term used
for seaweed throughout the Pacific. The rimu tree was named after ‘sea rimu’ seaweed on account of
its foliage resembling its marine namesake, not the other way around.
4.29. Marine life is cherished by Māori for many reasons other than its instrumental value such as food and
raw materials for other uses. For example, Māori observe characteristics in species that they use for
describing or modelling human behaviour and attributes. These ‘model’ species are embedded in
whakataukī (proverbial sayings), for instance “Kia mate ururoa, kei mate wheke (Die like a shark, don’t
die like an octopus)”, which advocates perseverance and resilience. An octopus is fairly passive when
caught but sharks fight tenaciously to the end, so this whakataukī encourages people to not give up
and overcome difficulties no matter how hard the struggle. Another whakataukī, “E kore te patiki e hoki
ki tona puehu (The flounder does not return to the sediment cloud it stirs up)”, advises people to not
repeat mistakes and move on to other opportunities. That is, learn from experience and make the
most of opportunities that come one’s way.
4.30. Marine species play a central role in kōrero o mua (traditional narratives) concerning the origin and
discovery of New Zealand. For example, Māori legends inform us that the North Island came into
being when the demi-god and trickster Māui hauled up a gigantic fish from the depths of the ocean.
This fish, ‘Te Ika a Māui’ (The Fish of Māui) – the Māori name for the North Island, was a stingray.
9
Decision on application for approval to import or manufacture Hempaguard X7 89909 for release (APP203090)
October 2017
According to another tradition, Kupe’s pursuit of a giant octopus called ‘Te Wheke a Muturangi’
(Muturangi’s octopus) across the Pacific Ocean led him to discovering New Zealand. It was during this
mission that Kupe’s wife, Hine-te-Aparangi, named this land ‘Aotearoa’ (land of the long white cloud).
4.31. Sea creatures are valued in Māori art. Motifs of mangō (sharks), whai (stingrays), pātiki (flounder)
depicted in kōwhaiwhai patterns on rafters, and pātiki on tukutuku (lattice-work wall panels), inside
whare nui (meeting houses) and whare kai (dining halls) portray the relationships and importance of
these species to local Māori.
4.32. In addition to the above species, there are many others e.g. pātangaroa (starfish) and
koromāungaunga (barnacles) that Māori valued for their intrinsic qualities as part of the natural order
of ecosystem relationships within the domain of Tangaroa.
4.33. Hempaguard X7 89909 will have harmful or fatal effects on organisms attaching onto the hull of
vessels treated with this substance, as it is designed to prevent biofouling by repelling or killing such
organisms. These organisms are likely to be of such types or in stages of development that they are
unsuitable for consumption or use by humans irrespective of the ecotoxic action of ablative surfaces.
Hempaguard X7 89909 is unlikely to pose an appreciable threat to culturally significant species
moving through or inhabiting the general vicinity of vessels treated with this substance, as these are
less likely to come into direct contact with ablative surfaces than ‘attaching’ ones.
Taha hauora (Human health)
4.34. Hempaguard X7 89909 is classified as a skin and eye irritant / corrosive, and contact sensitiser. It is
also harmful to human organs or systems and is a suspected carcinogen as well as a suspected
human reproductive or developmental toxicant. Hempaguard X7 89909 is acutely toxic when ingested
or inhaled. For these reasons, Hempaguard X7 89909 poses risk to taha hauora (human health)
particularly the dimensions of taha tinana (physical health and well-being) and taha wairua (spiritual
health and well-being obtained through the maintenance of a balance with nature and the protection of
mauri).
4.35. Exposure to Hempaguard X7 89909 may inhibit taha whānaunga – the responsibility to belong, care
for and share in the collective, including co-workers, relationships and workplace cohesion. There is a
risk that using this substance may compromise the ability to protect people where it is being used.
Ensuring the collective welfare and fostering a sense of well-being and safety amongst all involved is
important for maintaining taha whānaunga.
4.36. The potential for reproductive impairment and its implications for whakapapa is a serious matter for
Māori. Whakapapa is sacrosanct; it is pervasive in Māori art, architecture, carving, rituals and
literature, and is the fundamental basis of the Māori cosmogeny. Human reproduction and
transmission of ‘ira tangata’ (human life) from one generation to the next is hugely important to Māori
in a symbolic as well as ordinary sense.
4.37. To interfere with reproductive capability is to disrespect the unbroken human and spiritual thread that
stretches back to the first human procreated by Tāne-mahuta (deity of humans, forests and forest-
10
Decision on application for approval to import or manufacture Hempaguard X7 89909 for release (APP203090)
October 2017
dwelling species) and Hineahuone (earth-formed woman). The phrase ‘tīhei mauriora’ (the sneeze of
life), a common idiom, refers to the sneeze that brought Hineahuone to life and rendered her capable
of giving birth to humankind and is used to connect people with their mortal and spiritual origins.
4.38. Similarly, tampering with human growth and development may impair mauri (life principle, vital
essence) and ability to fulfil potential that all people were imbued with when human beings were first
created. Good physical health is necessary for optimal growth and development.
4.39. Māori working with Hempaguard X7 89909 may potentially be a vulnerable group, as Māori have a
significantly higher registration rates than non-Māori for a range of diseases and medical conditions
relating to human organs including heart, lungs, liver and kidney.
Ētahi atu mea (Other matters)
4.40. Hempaguard X7 89909 is not anticipated to pose a threat to culturally significant species in the
domains of Te Marae o Tāne (terrestrial ecosytems) and Te Marae o Maru (freshwater ecosystems)
including those associated with mahinga kai (food resources), rongoā (medicine and healing), pūeru
(textiles), rauemi raranga (weaving materials), taputapu (tools and equipment), mahi toi (arts),
whakarākei (ornamentation) and ritenga (rituals).
4.41. Hempaguard X7 89909 is not likely to adversely affect culturally significant species of Te Aitanga
Pepeke (insects, arthropods), ngā kararehe (quadrupeds), ngā manu (birds), ngā ngārara (reptiles)
me ngā rīroi (rodents).
4.42. It is noted that Hempaguard X7 89909 would be applied to vessel hulls by appropriately trained
professionals in controlled work areas.
4.43. Māori participate in a wide range of economic and leisure activities based on marine vessels including,
commercial trawling, recreational fishing and diving, sightseeing and tourism ventures (e.g. whale-
watching). Using Hempaguard X7 89909 on vessels involved with these activities may help operators
to provide cheaper and better products, services and experiences for consumers. This may have a
positive effect on taha hauora, particularly in respect of taha wairua (spiritual health and well-being)
and taha hinengaro (mental and emotional well-being).
4.44. Using Hempaguard X7 89909 to control the accumulation of aquatic organisms on the hulls of vessels
will produce economic and/or operational benefits for those owning or operating vessels, some of
whom are Māori.
4.45. Hempaguard X7 89909 provides an option that vessel owners and operators can consider as an
alternative to other antifouling products that are currently available.
He whakangāwari me te whakamaru (Mitigation and protection)
4.46. The risks to human health can be mitigated by stipulating that those applying the substance to vessels
should have approved handler status and use appropriate PPE e.g. double full body overalls, chemical
resistant gloves, covered safety footwear and full mask respiratory protection.
11
Decision on application for approval to import or manufacture Hempaguard X7 89909 for release (APP203090)
October 2017
4.47. Limiting use of Hempaguard X7 89909 to controlled work areas including restricted entry should avoid
inadvertently exposing bystanders to this substance, in particular vulnerable groups such as tamariki
(children), kaumātua (the elderly), ngā tūroro (the unwell) me ngā kūware (the unknowing or unaware).
4.48. Controls requiring appropriate collection and disposal of washdown wastewater and residual waste
arising from surface preparation of vessel hulls can minimise potential for off-target site contamination.
4.49. Potential risk to taonga species cannot be avoided or mitigated.
Manaakitanga (Due care)
4.50. Manaakitanga is about valuing people, acting with goodwill and beneficial purpose, showing respect,
caring for and protecting the well-being of people and the environment. Manaakitanga extends to
physical, spiritual, social and economic well-being – which can manifest in dimensions of taha hauora
(human health). Mitigation measures are available for managing risks associated with Hempaguard X7
89909 in relation to taha hauora. Keeping people safe and protecting the well-being of those operating
vessels or enjoying services and experiences based on vessels treated with Hempaguard X7 89909 is
consistent with the practice of manaakitanga.
Kupu whakatepe (Conclusion)
4.51. Based on the information provided, including the use pattern and the controls proposed to be assigned
to Hempaguard X7 89909, the overall potential risk to Māori interests is likely to be acceptable in
terms of Māori cultural beliefs and environmental frameworks.
The HSNO Act
Section 5(b) – recognise and provide for cultural well-being
4.52. This application is not likely to put overall cultural well-being of Māori at risk in terms of their cultural
beliefs and environmental frameworks.
Section 6(d) – take into account Māori relationship to the environment
4.53. The EPA’s cultural risk assessment considers potential risks and impacts on Māori interests including
the relationship of Māori to the environment, culturally significant species and resources, and
mātauranga (knowledge systems) and the tikanga (customary values and practices) associated with
these taonga. It has identified cultural concerns in relation to human health and marine organisms in
particular taonga food species. While the human health aspects can be avoided or mitigated, the
adverse effects on taonga species cannot. However, on balance the risks and benefits to Māori
interests are likely to be acceptable and align as a whole with Māori cultural beliefs and environmental
frameworks.
12
Decision on application for approval to import or manufacture Hempaguard X7 89909 for release (APP203090)
October 2017
Section 8 – take into account Treaty of Waitangi principles
The active protection principle i.e. the Crown has a duty to actively protect Māori interests.
4.54. The EPA has undertaken a cultural risk assessment to consider potential risks and impacts on Māori
interests as well as controls and mitigation measures for protecting Māori interests. As noted above,
the human health issues can be mitigated but the potential effects on taonga species cannot.
However, on balance the risks and benefits to Māori interests are likely to be acceptable and align as
a whole with Māori cultural beliefs and environmental frameworks.
The taonga principle i.e. ‘taonga’ include all valued resources and intangible cultural assets.
4.55. The scope of the EPA’s cultural risk assessment includes tangible and intangible taonga, such as
culturally significant species and resources, mātauranga (knowledge systems) and the tikanga
(customary values and practices) associated with these taonga.
Assessment of risks to society, the community and the market economy
4.56. No risks to society, communities or the market economy were identified from a release approval for
the importation or manufacture of Hempaguard X7 89909.
New Zealand’s international obligations
4.57. No international obligations were identified as being impacted by a release approval for the
importation or manufacture of Hempaguard X7 89909.
The effects of the substance being unavailable
4.58. The likely effects of the substance being unavailable was considered in accordance with section 29(1)
of the Act. It is considered that, should this substance not be available, it could lead to less consumer
choice.
Assessment of benefits
4.59. The antifouling paints reassessment (APP201051) determined that there are benefits to the use of
antifouling paints, which includes their use as a biosecurity tool to help prevent the spread of
unwanted organisms in New Zealand waters.
4.60. Another benefit identified for antifouling paints in APP201051 is that they provide cost and efficiency
benefits to vessel operators, as biological growth attached to hull surfaces create increased frictional
resistance which slows vessels down. By avoiding this, benefits are realised in terms of time spent
travelling, and the amount of fuel consumed.
4.61. In addition, benefits specific to copper were identified in APP201051. Copper is the main biocide used
in antifouling paints and is responsible for the majority of the paint’s efficacy and for the generic
benefits identified above.
4.62. The generic benefits identified above, are considered relevant to Hempaguard X7 89909. The EPA is
also satisfied that the availability of Hempaguard X7 89909 will provide beneficial economic effects for
13
Decision on application for approval to import or manufacture Hempaguard X7 89909 for release (APP203090)
October 2017
some businesses with the potential for flow-on effects to local communities and the New Zealand
economy, including improved consumer choice and greater market competition.
4.63. The applicant considers that a benefit of Hempaguard X7 89909 is that the product releases less
biocide to the aquatic environment, relative to other antifouling paints.
5. Variation of the prescribed controls
Modification of controls under section 77A of the Act
5.1. Section 77A of the Act also allows the EPA to add, vary, substitute, combine or delete controls if such
changes are more effective or more cost-effective in terms of managing the use and risks of the
substance, or are more likely to achieve their purpose than the prescribed controls.
5.2. It is necessary to vary or delete some of the prescribed controls and impose additional controls on the
approval for Hempaguard X7 89909. The relevant justifications for modifying the controls are outlined
in Table 2.
Table 2: Justification for the additional controls and variation/deletion of the prescribed controls
Control Justification
R-2
R-3
R-4
R-5
Antifouling paints controls
The antifouling paints reassessment (APP201051) imposed four additional controls (R-2 to
R-5) on all antifouling paints approved under the Act. These additional controls are applied to
the approval for Hempaguard X7 89909.
T5 Requirement for protective clothing and equipment
The prescribed controls include requirements in regulation 8 of Hazardous Substances
(Classes 6, 8, and 9 Controls) Regulations 2001 that people handling Hempaguard X7 89909
use protective clothing or equipment that prevents them from coming into contact with, or
inhaling the substance. This control is varied in accordance with APP201051 to better
manage the risks of human exposure to Hempaguard X7 89909.
This control will apply to any person applying or removing Hempaguard X7 89909, including
in locations that are not designated as workplaces.
I21-23, I25,
I28
EM8-9
D8
Requirement for safety data sheet
The outcome of APP201051 imposed an additional control (R-5), which specifies that safety
data sheets are to be supplied with antifouling paints. R-5 replaces the requirements of
prescribed controls I21, I22, I23, I25, I28, EM8, EM9 and D8; consequently, these controls
are deleted.
T6
E7
AH1
Approved handler/security requirements
The risks posed by Hempaguard X7 89909 to people and the environment can be adequately
mitigated without an approved handler requirement. A similar conclusion was made in the
antifouling paints reassessment (APP201051). Therefore, controls T6, E7 and AH1 are
deleted.
14
Decision on application for approval to import or manufacture Hempaguard X7 89909 for release (APP203090)
October 2017
Control Justification
TR1 Requirement for tracking
This control relates to tracking requirements and has been triggered by certain toxic and
ecotoxic properties of Hempaguard X7 89909. This control is varied to limit the tracking
requirements up to the point of sale to allow non-professional users to use this substance.
The risks that may arise after the point of retail sale of this substance are adequately
managed through other controls.
The risk assessment for Hempaguard X7 89909 did not identify any additional risk if the
substance is used in a non-professional setting, provided the controls in Appendix A are
complied with.
Use Control Requirement for use restriction
The risk assessment for Hempaguard X7 89909 is based on its use as an antifouling paint.
This is a key factor in preventing harmful exposures of people and the environment to the
substance. It is therefore necessary to apply a use control that restricts Hempaguard X7
89909 for use only as an antifouling paint.
EM12 Requirement for secondary containment
This control is varied to note that any quantities of the substance contained within pipework
are not required to be taken into account when determining whether a place is required to
have a secondary containment system.
The prescribed control specifies the emergency management requirements for secondary
containment of liquid hazardous substances (or those likely to liquefy in a fire). However, it
does not allow for dispensation where it is unnecessary for any pipework associated with the
stationary container systems to have secondary containment.
Schedules 8,
9, and 10
Stationary containers, secondary containment and unintended ignition requirements
The requirements of Schedules 8, 9 and 10 of the Hazardous Substances (Dangerous Goods
and Schedules Toxic Substances) Transfer Notice 2004 are applied to the approval for
Hempaguard X7 89909. These controls are considered to be more effective as the
prescribed controls do not address the risks associated with storage or use of Hempaguard
X7 89909 within stationary container systems (e.g. tanks). In addition, the prescribed controls
do not address all the risks associated with the secondary containment and unintended
ignition of Hempaguard X7 89909.
Assessment of control modifications
5.3. The modifications to the controls fulfil the legislative criteria under section 77A(4)(a) of the Act, as
relative to the prescribed controls, they are more effective with respect to their effect on the
management, use, and risks of the substance.
Review of controls for cost-effectiveness
5.4. The proposed controls, provided they are complied with, are the most cost-effective means of
managing the potential risks associated with Hempaguard X7 89909. The applicant was provided an
opportunity to comment on the cost-effectiveness. The applicant did not raise any concerns.
15
Decision on application for approval to import or manufacture Hempaguard X7 89909 for release (APP203090)
October 2017
6. Decision
6.1. Pursuant to section 29 of the Act, I have considered this application for approval under section 28 of
the Act. I have considered the effects of this substance throughout its life cycle, the controls that may
be imposed on this substance and the likely effects of this substance being unavailable.
6.2. I consider that, with controls in place, the risks to human health and to the environment are negligible,
and the benefits associated with the release of this substance will outweigh the adverse effects.
6.3. Hempaguard X7 89909 is approved for release with the controls in Appendix A, in accordance with
section 29 of the Act and clause 26 of the Hazardous Substances and New Organisms (Methodology)
Order 1998.
Dr Allan L Freeth Date: 16 October 2017
Chief Executive, EPA
16
Decision on application for approval to import or manufacture Hempaguard X7 89909 for release (APP203090)
October 2017
Appendix A: Controls applying to Hempaguard X7 89909
Please refer to the Hazardous Substances Regulations3 for the requirements prescribed for each control.
Hazardous Substances (Classes 1 to 5 Controls) Regulations 2001
Code Regulation Description Variation
F1 7 General test certification
requirements for hazardous
substance locations
F2 8 Restrictions on the carriage of
flammable substances on passenger
service vehicles
F3 55 General limits on flammable
substances
F5 58, 59 Requirements regarding hazardous
atmosphere zones for class 2.1.1,
2.1.2 and 3.1 substances
F6 60 – 70 Requirements to prevent unintended
ignition of class 2.1.1, 2.1.2 and 3.1
substances
F11 76 Segregation of incompatible
substances
F12 77 Requirement to establish a
hazardous substance locations if
flammable substances are present
F14 81 Test certification requirements for
facilities where class 2.1.1, 2.1.2 or
3.1 substances are present
F16 83 Controls on transit depots where
flammable substances are present
Hazardous Substances (Classes 6, 8, and 9 Controls) Regulations 2001
Code Regulation Description Variation
T1 11 – 27 Limiting exposure to toxic substances
through the setting of ADE, PDE or
TEL values
No ADE, PDE or TEL values are set for
any component of this substance at this
time.
T2 29, 30 Controlling exposure in places of work
through the setting of WES values
The EPA adopts as WES values for this
substance, and each component of this
substance, any applicable value specified
in WorkSafe New Zealand’s Workplace
3 The regulations can be found on the New Zealand Legislation website; http://www.legislation.co.nz
17
Decision on application for approval to import or manufacture Hempaguard X7 89909 for release (APP203090)
October 2017
Code Regulation Description Variation
Exposure Standards and Biological
Exposure Indices Document; 8th Edition4
T3 5(1), 6 Requirements for keeping records of
use
T4 7 Requirements for equipment used to
handle substances
T5 8 Requirements for protective clothing
and equipment
Subclause (1) of Reg. 8 of the Hazardous
Substances (Classes 6, 8, and 9
Controls) Regulations 2001 is replaced
by the following:
(1) Any person who handles the
substance must use protective
clothing or equipment that is
designed, constructed, and operated
to ensure that the person
(a) does not come into contact with
or inhale, the substance; and
(b) is not exposed to a
concentration of the substance
that exceeds the workplace
exposure standard (WES) for
that substance, if a WES for
that substance exists.
T7 10 Restrictions on the carriage of toxic or
corrosive substances on passenger
service vehicles
E1 32 – 45 Limiting exposure to ecotoxic
substances through the setting of EEL
values
No EEL values are set at this time and
the default EEL values are deleted.
E2 46 – 48 Restrictions on use of substances in
application areas
E5 5(2), 6 Requirements for keeping records of
use
E6 7 Requirements for equipment used to
handle substances
Hazardous Substances (Identification) Regulations 2001
Code Regulation Description Variation
I1 6, 7, 32 – 35,
36(1) – (7)
Identification requirements, duties of
persons in charge, accessibility,
4 Or any subsequent version of this Standard approved or endorsed by the EPA.
18
Decision on application for approval to import or manufacture Hempaguard X7 89909 for release (APP203090)
October 2017
Code Regulation Description Variation
comprehensibility, clarity and
durability
I2 8 Priority identifiers for corrosive
substances
I3 9 Priority identifiers for ecotoxic
substances
I5 11 Priority identifiers for flammable
substances
I8 14 Priority identifiers for toxic substances
I9 18 Secondary identifiers for all
hazardous substances
I10 19 Secondary identifiers for corrosive
substances
I11 20 Secondary identifiers for ecotoxic
substances
I13 22 Secondary identifiers for flammable
substances
I16 25 Secondary identifiers for toxic
substances
I17 26 Use of generic names
I18 27 Requirements for using concentration
ranges
I19 29 – 31 Additional information requirements,
including situations where substances
are in multiple packaging
I20 36(8) Durability of information for class 6.1
substances
I29 51, 52 Signage requirements
I30 53 Advertising corrosive and toxic
substances
Hazardous Substances (Packaging) Regulations 2001
Code Regulation Description Variation
P1 5, 6, 7(1), 8 General packaging requirements
P3 9 Criteria that allow substances to be
packaged to a standard not meeting
Packing Group I, II or III criteria
19
Decision on application for approval to import or manufacture Hempaguard X7 89909 for release (APP203090)
October 2017
Code Regulation Description Variation
P5 11 Packaging requirements for
flammable liquids
P13 19 Packaging requirements for toxic
substances
P14 20 Packaging requirements for corrosive
substances
P15 21 Packaging requirements for ecotoxic
substances
PG3 Schedule 3 Packaging requirements equivalent to
UN Packing Group III
PS4 Schedule 4 Packaging requirements as specified
in Schedule 4
Hazardous Substances (Disposal) Regulations 2001
Code Regulation Description Variation
D2 6 Disposal requirements for flammable
substances
D4 8 Disposal requirements for toxic and
corrosive substances
D5 9 Disposal requirements for ecotoxic
substances
D6 10 Disposal requirements for packages
D7 11, 12 Information requirements for
manufacturers, importers and
suppliers, and persons in charge
Hazardous Substances (Emergency Management) Regulations 2001
Code Regulation Description Variation
EM1 6, 7, 9 – 11 Level 1 information requirements for
suppliers and persons in charge
EM2 8(a) Information requirements for corrosive
substances
EM6 8(e) Information requirements for toxic
substances
EM7 8(f) Information requirements for ecotoxic
substances
EM10 21 – 24 Fire extinguisher requirements
20
Decision on application for approval to import or manufacture Hempaguard X7 89909 for release (APP203090)
October 2017
Code Regulation Description Variation
EM11 25 – 34 Level 3 emergency management
requirements: duties of person in
charge, emergency response plans
EM12 35 – 41 Level 3 emergency management
requirements: secondary containment
The following subclauses are added after
subclause (3) of regulation 36:
(4) For the purposes of this regulation, and
regulations 37 to 40, where this
substance is contained in pipework that
is installed and operated so as to
manage any loss of containment in the
pipework it—
(a) is not to be taken into account in
determining whether a place is
required to have a secondary
containment system; and
(b) is not required to be located in a
secondary containment system.
(5) In this clause, pipework—
(a) means piping that—
(i) is connected to a stationary
container; and
(ii) is used to transfer a hazardous
substance into or out of the
stationary container; and
(b) includes a process pipeline or a
transfer line.
EM13 42 Level 3 emergency management
requirements: signage
Hazardous Substances (Tracking) Regulations 2001
Code Regulation Description Variation
TR1 4(1), 5, 6 General tracking requirements
Subclause (1) of regulation 4 is deleted and
substituted with the following subclause:
(1) The location and movement of every
tracked substances must be recorded at each
stage of its lifecycle up until, and including,
the point of retail sale, in accordance with
these regulations.
Hazardous Substances (Tank Wagons and Transportable Containers) Regulations 2004
Code Regulation Description Variation
Tank
Wagon
4 – 43, as
applicable
Controls relating to tank wagons
and transportable containers
21
Decision on application for approval to import or manufacture Hempaguard X7 89909 for release (APP203090)
October 2017
Controls added under section 77A of the Act
Code Control
Use restriction No person may use this substance for any purpose other than as an antifouling
paint to prevent, by the slow release of biocides, the build-up of aquatic
organisms on the hulls of vessels or other surfaces in contact with water.
Schedules 8, 9
and 10
The controls relating to stationary container systems, secondary containment
and unintended ignition of flammable substances, as set out in schedules 8, 9
and 10 of the Hazardous Substances (Dangerous Goods and Scheduled Toxic
Substances) Transfer Notice 20045 (Supplement to the New Zealand Gazette, 26
March 2004, No 35, page 767), as amended, shall apply to this substance,
notwithstanding clause 1(1) of Schedules 8 and 9 and clause 1 of Schedule 10.
R-2 Controlled work area and signage
(1) Any person applying the substance must ensure that application of the
substance is carried out in a controlled work area.
(2) The controlled work area, as referred to in subclause (1) is a designated
area in which antifouling paints are applied, using a method and located
such that off-target deposition of the substance, including onto bystanders,
is avoided by taking all practicable steps.
(3) Any person applying the substance in a controlled work area must avoid
off-target deposition of the substance. To avoid doubt, this requirement
includes avoiding off-target deposition of the substance onto persons
outside of, but within the immediate vicinity of, the controlled work area.
Signage
(4) Any person applying the substance must ensure that signs are placed at
every point of entrance into the controlled work area. Signs must be posted
from the start of application, until the end of the application.
(5) Signs erected in accordance with (4) must—
(a) warn that an application is being carried out using a substance that is
toxic to humans;
(b) identify the person in charge of the application;
(c) state that entry into the controlled work area is not permitted unless
personal protective equipment (PPE) is worn by the person entering
the controlled work area; and
(d) comply with regulation 34 and regulation 35 of the Hazardous
Substances (Identification) Regulations 2001 as if the distance
referred to in regulation 35(3) is not less than 10 metres.
R-3 Collection of substances from maintenance activities
(1) Any person who removes any antifouling paint coating from the hull of a
boat must ensure that waste containing antifouling paint residue is
collected; and
(2) All collected waste, as referred to in subclause (1), must be disposed of in
accordance with the Hazardous Substances (Disposal) Regulations 2001.
5 http://www.epa.govt.nz/Publications/Transfer-Notice-35-2004.pdf
22
Decision on application for approval to import or manufacture Hempaguard X7 89909 for release (APP203090)
October 2017
Code Control
R-4
Additional labelling requirements
For formulated antifouling substances:
(1) Labels must include the following statements (or similar):
(a) When applying this substance by spraying, you must sufficiently
enclose the area to ensure that the substance is not deposited on off-
target sites and has no adverse effects on bystanders
(b) You must ensure that waste generated from maintenance activities
does not enter the environment
(2) A person must not supply a hazardous substance to any other person
unless the substance label shows the information required by (1).
R-5 Safety Data Sheets
(1) A person, when selling or supplying this substance at any quantity, must
provide a safety data sheet for the substance to the recipient if—
(a) the substance is likely to be used in a place of work; and
(b) they have not previously supplied a safety data sheet for that
substance to the recipient
(2) In each place of work where the substance is manufactured, stored, or
used, the person in charge of the place must ensure that every person
handling the substance has access to a safety data sheet for that
substance.
(3) The safety data sheet must be available to a person handling the substance
within 10 minutes, and be readily understandable by any fully trained
persons required to have access to it.
(4) A person who manufactures or supplies a substance in New Zealand, or
imports a substance into New Zealand must, if asked to do so by any
person in charge of a place of work where a substance is stored or used,
give that person the required safety data sheet.
(5) Information required on a safety data sheet must be provided under the
following 16 general headings in the order listed below, and must include
the information referred to under those headings:
Section 1 - Identification of the substance and supplier—
(i) product name
(ii) recommended uses
(iii) name of the supplier, New Zealand contact details including an
emergency contact.
Section 2 - Hazards identification—
(i) a description of the hazards of the substance, which may include its
HSNO hazard classification
(ii) hazard information, including signal words, hazard statement(s) and
precautionary statement(s).
Section 3 - Composition/information on ingredients—
23
Decision on application for approval to import or manufacture Hempaguard X7 89909 for release (APP203090)
October 2017
Code Control
(i) in the case of single component substances, their chemical identity,
including common names and synonyms, CAS number and any
impurities that are themselves hazardous
(ii) in the case of substances that are mixtures, the chemical identity of
each hazardous ingredient, their CAS number and their concentration
ranges.
Section 4 - First aid measures—
(i) first aid instructions according to each relevant route of exposure
(ii) whether medical attention is required, and its urgency
(iii) information on the most important symptoms and effects, acute and
delayed, from exposure.
Section 5 - Fire fighting measures—
(i) information on the appropriate type of extinguishers or fire-fighting
agents, including extinguishers that may not be appropriate for a
particular situation
(ii) any advice on hazards that may arise from combustion products
(iii) precautions for fire fighters and protective clothing requirements.
Section 6 - Accidental release measures—
(i) advice on protective clothing requirements and emergency
procedures
(ii) any environmental precautions from accidental spills and release
(iii) advice on how to contain and clean up a spill or release;
Section 7 - Handling and storage—
(i) precautions for safe handling
(ii) conditions for safe storage, including any incompatibilities.
Section 8 - Exposure controls/personal protection—
(i) exposure limits set for the substance or any of its components, or in
their absence, relevant overseas exposure limits
(ii) engineering controls
(iii) individual protection measures, including personal protective
equipment.
Section 9 - Physical and chemical properties—
(i) a description of relevant physical and chemical properties for the
substance, including units of measurement and reference conditions
where appropriate
(ii) where necessary for interpretation of data reported, the method of
determination.
Section 10 - Stability and reactivity—
(i) an indication of the chemical stability of the substance under normal
and anticipated storage and handling conditions
(ii) a list of conditions to avoid to prevent a hazardous situation; and
24
Decision on application for approval to import or manufacture Hempaguard X7 89909 for release (APP203090)
October 2017
Code Control
(iii) information on incompatible substances or materials.
Section 11 - Toxicological information—
(i) a full description of the toxicological (health) effects, including the
symptoms or signs of injury or ill health associated with each likely
route of exposure
(ii) the dose, concentration or conditions of exposure likely to cause injury
or ill health
(iii) a summary of the data used to identify the health effects.
Section 12 - Ecological information—
(i) ecotoxicity
(ii) persistence and degradability
(iii) mobility.
Section 13 - Disposal considerations—
(i) disposal methods, including disposal of packaging
(ii) special precautions to be taken during disposal
(iii) any method of disposal that should not be used.
Section 14 - Transport information—
If relevant,
(i) the UN number
(ii) the proper shipping name
(iii) the UN Dangerous Goods class and subsidiary risk
(iv) the UN Packing Group.
Section 15 - Regulatory information—
(i) HSNO approval number
(ii) information on any other regulatory requirements such as the
controlled work area and signage requirements.
Section 16 - Other information—
(i) date of preparation or revision of the safety data sheet
(ii) a key/legend to abbreviations and acronyms used.
(6) Where a substance is being transported, a safety data sheet is not required
if—
(a) there is in the vehicle concerned documentation complying with the
Land Transport Rule whilst being transported by land; or
(b) there is in the ship concerned documentation complying with the
Maritime Rule whilst being transported by sea; or
(c) there is in the aircraft concerned documentation complying with the
Civil Aviation Rule whilst being transported by air.
25
Decision on application for approval to import or manufacture Hempaguard X7 89909 for release (APP203090)
October 2017
Definitions
Unless defined below, terms used in the controls have the same meaning as defined in the Act or regulations
made under the Act.
Term Definition
RPE 40 e.g. full face mask EN 136 and P3 filter; powered hood, helmet or blouse model TH3 EN 146/EN
12941; power-assisted full face mask model TM3 EN 147/EN 12942.
Water
Means water in all its physical forms, whether flowing or not, and whether over or under ground, but
does not include water in any form while in a pipe, tank or cistern or water used in the dilution of the
substance prior to application.